Keipert Susanne, Ost Mario
Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
Institute of Anatomy, University of Leipzig, Leipzig, Germany.
Trends Endocrinol Metab. 2021 Nov;32(11):904-915. doi: 10.1016/j.tem.2021.08.008. Epub 2021 Sep 13.
Fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) are established as stress-responsive cytokines that can modulate energy balance by increasing energy expenditure or suppressing food intake, respectively. Despite their pharmacologically induced beneficial effects on obesity and comorbidities, circulating levels of both cytokines are elevated during obesity and related metabolic complications. On the other hand, endocrine crosstalk via FGF21 and GDF15 was also reported to play a crucial role in genetically modified mouse models of mitochondrial perturbations leading to diet-induced obesity (DIO) resistance. This review aims to dissect the complexities of endogenous FGF21 and GDF15 action in obesity versus DIO resistance for the regulation of energy balance in metabolic health and disease.
成纤维细胞生长因子21(FGF21)和生长分化因子15(GDF15)是公认的应激反应细胞因子,它们可分别通过增加能量消耗或抑制食物摄入来调节能量平衡。尽管它们在药理学上对肥胖症和合并症具有有益作用,但在肥胖症和相关代谢并发症期间,这两种细胞因子的循环水平都会升高。另一方面,据报道,在导致饮食诱导性肥胖(DIO)抗性的线粒体扰动转基因小鼠模型中,通过FGF21和GDF15的内分泌串扰也起着关键作用。本综述旨在剖析内源性FGF21和GDF15在肥胖与DIO抗性中作用的复杂性,以调节代谢健康和疾病中的能量平衡。